Mankind Pharma on Wednesday said its consolidated net profit increased 55% to Rs 460 crore for the third quarter ended December 2023.
The company had posted a net profit of Rs 296 crore in the October-December quarter of the last fiscal.
Its revenue from operations rose to Rs 2,607 crore in the period under review from Rs 2,091 crore in the year-ago period, Mankind Pharma said in a statement.
Shares of the company ended 2.79% down at Rs 1,999.55 apiece on the BSE.
Add us to your Preferences
Set as your preferred source on Google
ADVERTISEMENT
RECOMMENDED FOR YOU
India's Direct Tax Collections Jump 9.18% To Rs 10.8 Lakh Crore Over Fewer Refunds
Sep 19, 2025
NMDC Steel Shares Jump Nearly 16% After Profitable Q1
Aug 13, 2025
Mankind Pharma Confident GLP-1 Won't Dent Anti-Diabetic Portfolio Growth
Aug 09, 2025
Mankind Pharma Q1 Results Preview: Revenue Likely To Rise, Net Profit May Decline
Jul 30, 2025
POPULAR
1
Kolkata Rains LIVE Updates: Seven Dead; Train And Metro Services Suspended As Heavy Rain Causes Waterlogging
2
Navratri 2025, Day 3: Which Colour To Wear Tomorrow? Check Significance, Rituals And More
3
Gold Hits Fresh Record High Again Driven By Festive Demand — Check Rates In Delhi, Chennai, Other Cities
4
Tata Investment Shares Soar To 18-Month High After Company Locks Record Date For Stock Split
5